|
1
|
Ma J, Siegel R and Jemal A: Pancreatic
cancer death rates by race among US men and women, 1970–2009. J
Natl Cancer Inst. 105:1694–1700. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Christofk HR, Vander Heiden MG, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mazurek S: Pyruvate kinase type M2: A key
regulator of the metabolic budget system in tumor cells. Int J
Biochem Cell Biol. 43:969–980. 2011. View Article : Google Scholar
|
|
5
|
Marie J, Levin MJ, Simon MP and Kahn A:
Genetic and epigenetic control of the pyruvate kinase isozymes in
mammals. Isozymes Curr Top Biol Med Res. 7:221–240. 1983.PubMed/NCBI
|
|
6
|
Dong G, Mao Q, Xia W, Xu Y, Wang J, Xu L
and Jiang F: PKM2 and cancer: The function of PKM2 beyond
glycolysis. Oncol Lett. 11:1980–1986. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li C, Zhao Z, Zhou Z and Liu R: PKM2
promotes cell survival and invasion under metabolic stress by
enhancing Warburg effect in pancreatic ductal adenocarcinoma. Dig
Dis Sci. 61:767–773. 2016. View Article : Google Scholar
|
|
8
|
Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang
L, You MJ, Koh MY, Cote G, Aldape K, et al: EGFR-induced and PKCε
monoubiquitylation-dependent NF-κB activation upregulates PKM2
expression and promotes tumorigenesis. Mol Cell. 48:771–784. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong N, Ojo D, Yan J and Tang D: PKM2
contributes to cancer metabolism. Cancer Lett. 356:184–191. 2015.
View Article : Google Scholar
|
|
10
|
Luo W, Hu H, Chang R, Zhong J, Knabel M,
O'Meally R, Cole RN, Pandey A and Semenza GL: Pyruvate kinase M2 is
a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell.
145:732–744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang W, Xia Y, Hawke D, Li X, Liang J,
Xing D, Aldape K, Hunter T, Alfred Yung WK and Lu Z: PKM2
phosphorylates histone H3 and promotes gene transcription and
tumorigenesis. Cell. 150:685–696. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goldberg MS and Sharp PA: Pyruvate kinase
M2-specific siRNA induces apoptosis and tumor regression. J Exp
Med. 209:217–224. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bell SP and Dutta A: DNA replication in
eukaryotic cells. Annu Rev Biochem. 71:333–374. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pegg AE:
Spermidine/spermine-N(1)-acetyltransferase: A key metabolic
regulator. Am J Physiol Endocrinol Metab. 294:E995–E1010. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lockney NA, Zhang M, Lu Y, Sopha SC,
Washington MK, Merchant N, Zhao Z, Shyr Y, Chakravarthy AB and Xia
F: Pyruvate kinase muscle isoenzyme 2 (PKM2) expression is
associated with overall survival in pancreatic ductal
adenocarcinoma. J Gastrointest Cancer. 46:390–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pegg AE: Polyamine metabolism and its
importance in neoplastic growth and a target for chemotherapy.
Cancer Res. 48:759–774. 1988.PubMed/NCBI
|
|
17
|
Pegg AE: Mammalian polyamine metabolism
and function. IUBMB Life. 61:880–894. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Childs AC, Mehta DJ and Gerner EW:
Polyamine-dependent gene expression. Cell Mol Life Sci.
60:1394–1406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nowotarski SL, Woster PM and Casero RA Jr:
Polyamines and cancer: Implications for chemotherapy and
chemoprevention. Expert Rev Mol Med. 15:e32013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takigawa M, Verma AK, Simsiman RC and
Boutwell RK: Inhibition of mouse skin tumor promotion and of
promoter-stimulated epidermal polyamine biosynthesis by
alpha-difluoromethylornithine. Cancer Res. 43:3732–3738.
1983.PubMed/NCBI
|
|
21
|
Gupta ED, Pachauri M, Ghosh PC and Rajam
MV: Targeting polyamine biosynthetic pathway through RNAi causes
the abrogation of MCF 7 breast cancer cell line. Tumour Biol.
37:1159–1171. 2016. View Article : Google Scholar
|
|
22
|
Russell DH: Increased polyamine
concentrations in the urine of human cancer patients. Nat New Biol.
233:144–145. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Krüger A, Vowinckel J, Mülleder M, Grote
P, Capuano F, Bluemlein K and Ralser M: Tpo1-mediated spermine and
spermidine export controls cell cycle delay and times antioxidant
protein expression during the oxidative stress response. EMBO Rep.
14:1113–1119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cross CE, Halliwell B, Borish ET, Pryor
WA, Ames BN, Saul RL, McCord JM and Harman D: Oxygen radicals and
human disease. Ann Intern Med. 107:526–545. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chio IIC and Tuveson DA: ROS in cancer:
The burning question. Trends Mol Med. 23:411–429. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liou GY and Storz P: Reactive oxygen
species in cancer. Free Radic Res. 44:479–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Galadari S, Rahman A, Pallichankandy S and
Thayyullathil F: Reactive oxygen species and cancer paradox: To
promote or to suppress? Free Radic Biol Med. 104:144–164. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng B, Peng J, Mollayup A, Bakri A, Guo
L, Zheng J and Xu H: Construction of a prognostic prediction system
for pancreatic ductal adenocarcinoma to investigate the key
prognostic genes. Mol Med Rep. 17:216–224. 2018.
|
|
30
|
Badea L, Herlea V, Dima SO, Dumitrascu T
and Popescu I: Combined gene expression analysis of whole-tissue
and microdissected pancreatic ductal adenocarcinoma identifies
genes specifically overexpressed in tumor epithelia.
Hepatogastroenterology. 55:2016–2027. 2008.
|
